← Back to Search

Local Anesthetic

Serratus Anterior Plane Block for Rib Fractures

N/A
Waitlist Available
Research Sponsored by Rhode Island Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to test a new method called Serratus Anterior Plane Block in patients with rib fractures. The trial wants to see if this new method can help reduce pain, improve breathing, and

Who is the study for?
This trial is for emergency department patients with rib fractures. It's designed to see if a regional anesthesia technique called the Serratus Anterior Plane Block can help manage pain better and reduce opioid use compared to standard care.
What is being tested?
The study tests the effectiveness of Ultrasound Guided Serratus Anterior Plane Block (UG-SAPB) on improving pain, breathing function, and coughing ability, as well as decreasing the need for opioid painkillers in patients with broken ribs.
What are the potential side effects?
Potential side effects may include discomfort at the injection site, bleeding or bruising, infection risk from needle insertion, and possible temporary weakness or numbness in the chest wall.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
PIC Score
Secondary study objectives
Total oral morphine equivalents over the first 24 hours

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention arm (Undergoes SAPB)Experimental Treatment2 Interventions
Patients randomized to this arm will receive the Serratus Anterior Plane block.
Group II: ControlActive Control1 Intervention
Usual care. No changes made or recommended to patients randomized to the control arm.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Serratus Anterior Plane Block
2022
N/A
~500
Ropivacaine injection
2012
Completed Phase 4
~510

Find a Location

Who is running the clinical trial?

Rhode Island HospitalLead Sponsor
263 Previous Clinical Trials
68,755 Total Patients Enrolled
~27 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top